{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:18:59Z","timestamp":1787797139820,"version":"build-2784847793"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.vaccine.2026.128997","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T07:03:33Z","timestamp":1786518213000},"page":"128997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effectiveness of NmCV-5 vaccine against meningococcal meningitis in an outbreak setting in Niger: results from a case-control study"],"prefix":"10.1016","volume":"90","author":[{"given":"Laura V.","family":"Cooper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medard","family":"Djedanem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assan Abdoul","family":"Nasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalidou","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kourouma","family":"Mamadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camara","family":"Ibrahima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahamadou","family":"Doutchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Baruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katya","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anderson","family":"Latt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement","family":"Lingani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Bita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isha","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Swarthout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ousmane","family":"Guindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Pezzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elhadji Ibrahim","family":"Tassiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Coldiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128997_bb0005","doi-asserted-by":"crossref","DOI":"10.12688\/wellcomeopenres.24771.1","article-title":"Updating the meningitis belt: associations between environmental factors and epidemic meningitis risk across Africa","volume":"10","author":"Cliff","year":"2025","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.vaccine.2026.128997_bb0010","series-title":"Standard operating procedures for surveillance of meningitis preparedness and response to epidemics in Africa","year":"2018"},{"key":"10.1016\/j.vaccine.2026.128997_bb0015","first-page":"56","article-title":"Meningococcal A conjugate vaccine coverage in the meningitis belt of Africa from 2010 to 2021: a modelling study","author":"Bender","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.vaccine.2026.128997_bb0020","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/infdis\/jiv211","article-title":"The diversity of meningococcal carriage across the African meningitis belt and the impact of vaccination with a group a meningococcal conjugate vaccine","volume":"212","author":"Ali","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.128997_bb0025","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1016\/j.vaccine.2015.09.107","article-title":"Response thresholds for epidemic meningitis in sub-Saharan Africa following the introduction of MenAfriVac","volume":"33","author":"Trotter","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128997_bb0030","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S1473-3099(20)30239-5","article-title":"Meningococcal carriage 7 years after introduction of a serogroup a meningococcal conjugate vaccine in Burkina Faso: results from four cross-sectional carriage surveys","volume":"20","author":"Mbaeyi","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.128997_bb0035","first-page":"551","article-title":"Control of epidemic meningitis in countries in the African meningitis belt","volume":"99","author":"World Health Organisation","year":"2023","journal-title":"Wkly Epidemiol. Rec."},{"key":"10.1016\/j.vaccine.2026.128997_bb0040","series-title":"Defeating meningitis BY 2030: a global road map","year":"2021"},{"key":"10.1016\/j.vaccine.2026.128997_bb0045","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S1473-3099(18)30400-6","article-title":"Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups a, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study","volume":"18","author":"Chen","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.128997_bb0050","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1056\/NEJMoa2013615","article-title":"Meningococcal serogroup ACWYX conjugate vaccine in Malian toddlers","volume":"384","author":"Tapia","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vaccine.2026.128997_bb0055","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0035-9203(99)90106-2","article-title":"Manson {lecture}: meningococcal meningitis in Africa","volume":"93","author":"Greenwood","year":"1999","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2026.128997_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2026.128390","article-title":"Enhanced passive safety surveillance during the first use of the meningococcal vaccine a\/C\/W\/Y\/X conjugate for outbreak response in Niger and Nigeria","volume":"79","author":"Menang","year":"2026","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128997_bb0065","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiag116","article-title":"Bacterial meningitis epidemiology in Burkina Faso and Niger\u2014high-risk countries in the Meningitis Belt of sub-Saharan Africa, 2015\u20132023","author":"Pinell-McNamara","year":"2026","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.128997_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.vaccine.2026.128997_bb0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(13)61612-8","article-title":"Effect of a serogroup a meningococcal conjugate vaccine (PsA\u2013TT) on serogroup a meningococcal meningitis and carriage in Chad: a community study","volume":"383","author":"Daugla","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128997_bb0080","first-page":"780","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.vaccine.2026.128997_bb0085","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(25)00046-7","volume":"405","author":"Diallo","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128997_bb0090","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1003812","article-title":"Immunogenicity and {safety} of a {meningococcal} {A} {conjugate} {vaccine} in {Africans}","volume":"364","author":"Sow","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vaccine.2026.128997_bb0095","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1056\/NEJMoa2214924","article-title":"Meningococcal ACWYX conjugate vaccine in 2-to-29-year-olds in Mali and Gambia","volume":"388","author":"Haidara","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vaccine.2026.128997_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182575","article-title":"Investigation of correlates of protection against pharyngeal carriage of Neisseria meningitidis genogroups W and Y in the African meningitis belt","volume":"12","author":"Cooper","year":"2017","journal-title":"PLoS One"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26008066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26008066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:09:54Z","timestamp":1787796594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26008066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":20,"alternative-id":["S0264410X26008066"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128997","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of NmCV-5 vaccine against meningococcal meningitis in an outbreak setting in Niger: results from a case-control study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128997"}}